Commonwealth Equity Services’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
Commonwealth Equity Services's PPH Position: Q3 2026 in Review
Commonwealth Equity Services reduced its VanEck Pharmaceutical ETF (PPH) stake by 1.1% in Q3 2026, selling an estimated $13.6K and leaving 10,699 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2539.
Commonwealth Equity Services first reported a position in PPH in Q2 2020 and has held it in 26 quarters since. The position peaked at $1.93M in Q1 2024. 154 funds tracked by Wall St. Rank hold PPH as of Q3 2026.
- Commonwealth Equity Services held 10,699 shares of VanEck Pharmaceutical ETF worth $1.17M as of Q3 2026.
- Commonwealth Equity Services sold 122 VanEck Pharmaceutical ETF shares in Q3 2026, an estimated $13.6K.
- VanEck Pharmaceutical ETF made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q3 2026, its #2539 holding.
- Commonwealth Equity Services first reported a position in VanEck Pharmaceutical ETF in Q2 2020 and has held it in 26 quarters since.
- Commonwealth Equity Services's VanEck Pharmaceutical ETF position peaked at $1.93M in Q1 2024.
- 154 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.
Based on Commonwealth Equity Services's 13F filing for Q3 2026, filed 2 Nov 2026.